Resultados de la búsqueda 361-370 of 14771 for Hyperuricaemia / gout risk
... risk factors for outcomes and regional/center differences; and facilitate funded clinical trials of new therapies and collaboration with the PAH community ...
The purpose of this study is to determine whether transverse/sigmoid sinus junction stenting reduces the risk of recurrent cerebrospinal fluid (CSF) leak in ...
News. abril 2025. Mayo Clinic Q and A: Is intermittent fasting a helpful practice or health risk? April 15, 2025, 02:02 p.m. CDT ...
To provide a comprehensive review of Mayo Clinic's experience with volar SLIL capsulodesis; Investigate the relationships between patient risk factors and ...
Determine the preexisting and therapy-emergent germline and somatic variants associated with an increased risk of clonal and non-clonal cytopenia following CAR- ...
Testing Docetaxel-Cetuximab Or The Addition Of An Immunotherapy Drug, Atezolizumab, To The Usual Chemotherapy And Radiation Therapy In High-Risk Head And Neck ...
Despite not needing therapy, these patients have significant immune dysfunction. This may lead to an increased risk of serious infections requiring ...
This phase III trial studies whether inotuzumab ozogamicin added to post-induction chemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia ...
The purpose of this study is to characterize TRPC6 risk variants for doxorubicin-related cardiotoxicity in prospectively collected samples from breast cancer ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?